0001555280-23-000168.txt : 20230525
0001555280-23-000168.hdr.sgml : 20230525
20230525161304
ACCESSION NUMBER: 0001555280-23-000168
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230523
FILED AS OF DATE: 20230525
DATE AS OF CHANGE: 20230525
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PECK KRISTIN C
CENTRAL INDEX KEY: 0001488267
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35797
FILM NUMBER: 23960624
MAIL ADDRESS:
STREET 1: C/O ZOETIS INC.
STREET 2: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zoetis Inc.
CENTRAL INDEX KEY: 0001555280
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460696167
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 973-822-7000
MAIL ADDRESS:
STREET 1: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
4
1
wf-form4_168504556573436.xml
FORM 4
X0407
4
2023-05-23
0
0001555280
Zoetis Inc.
ZTS
0001488267
PECK KRISTIN C
C/O ZOETIS INC.
10 SYLVAN WAY
PARSIPPANY
NJ
07054
1
1
0
0
Chief Executive Officer
1
Common Stock
2023-05-23
4
M
0
13000
41.83
A
69843
D
Common Stock
2023-05-23
4
S
0
8665
176.149
D
61178
D
Common Stock
2023-05-23
4
S
0
2235
176.9376
D
58943
D
Common Stock
2023-05-23
4
S
0
2100
177.88
D
56843
D
Common Stock
793.228
I
401(k)
Stock Option
2023-05-23
4
M
0
13000
0
D
Common Stock
13000.0
309014
D
Stock Option
162.07
Common Stock
67148.0
67148
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2023.
The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.595 to $176.5871, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.6465 to $177.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Represents the common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan, as of March 31, 2023.
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
13,000 options granted February 19, 2016 at an exercise price of $41.83 per option.
Each option vests on the third anniversary of the date of grant.
Each option expires on the tenth anniversary of the date of grant.
37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 22,250 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option; and 54,751 options granted February 8, 2022 at an exercise price of $201.30 per option.
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
One-third of each option will vest on the first, second and third anniversaries of the date of grant.
/s/ Brenda Santuccio, as Attorney-in-Fact
2023-05-25